Risk Prediction Model for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement

References

• Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43(4):698–703. doi:10.1016/j.jacc.2003.11.026
   Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–289. doi:10.1016/j.jacc.2017.03.011
   Web of Science ®Google Scholar
• Holmes DR Jr., Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. Ann Thorac Surg. 2016;101(2):789–800. doi:10.1016/j.athoracsur.2015.10.049
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol. 2011;9(1):15–29. doi:10.1038/nrcardio.2011.164
   PubMed Web of Science ®Google Scholar
• Genereux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59(25):2317–2326. doi:10.1016/j.jacc.2012.02.022
   PubMed Web of Science ®Google Scholar
• Cao C, Ang SC, Indraratna P, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg. 2013;2(1):10–23. doi:10.3978/j.issn.2225-319X.2012.11.09
   PubMedGoogle Scholar
• Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35(24):1588–1598. doi:10.1093/eurheartj/eht381
   Web of Science ®Google Scholar
• Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv. 2016;9(21):2200–2209. doi:10.1016/j.jcin.2016.08.034
   PubMed Web of Science ®Google Scholar
• Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging. 2017;10:1139–1147. doi:10.1016/j.jcmg.2016.11.020
   Web of Science ®Google Scholar
• Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT registry. JACC Cardiovasc Interv. 2016;9(21):2189–2199. doi:10.1016/j.jcin.2016.07.026
   PubMed Web of Science ®Google Scholar
• Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129–140. doi:10.1016/j.jacc.2014.04.033
   PubMed Web of Science ®Google Scholar
• Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015;8(1Pt A):60–69. doi:10.1016/j.jcin.2014.07.022
   PubMed Web of Science ®Google Scholar
• Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35(24):1599–1607. doi:10.1093/eurheartj/eht376
   PubMed Web of Science ®Google Scholar
• Schroeter T, Linke A, Haensig M, et al. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace. 2012;14(12):1759–1763. doi:10.1093/europace/eus191
   PubMed Web of Science ®Google Scholar
• Agarwal S, Sud K, Shishehbor MH. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003–2011. J Am Coll Cardiol. 2016;67(16):1901–1913. doi:10.1016/j.jacc.2016.02.040
   PubMed Web of Science ®Google Scholar
• Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–2076. doi:10.1016/j.jacc.2015.03.518
   PubMed Web of Science ®Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi:10.1002/(ISSN)1097-0142
   PubMed Web of Science ®Google Scholar
• Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003635. doi:10.1161/CIRCINTERVENTIONS.115.003635
   PubMed Web of Science ®Google Scholar
• Weber M, Bruggemann E, Schueler R, et al. Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol. 2015;104(11):964–974. doi:10.1007/s00392-015-0865-9
   Web of Science ®Google Scholar
• Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(5):524–530. doi:10.1016/j.jcin.2010.01.017
   PubMed Web of Science ®Google Scholar
• Kawashima T, Sato F. Visualizing anatomical evidences on atrioventricular conduction system for TAVI. Int J Cardiol. 2014;174(1):1–6. doi:10.1016/j.ijcard.2014.04.003
   PubMed Web of Science ®Google Scholar
• Moreno R, Dobarro D, Lopez de Sa E, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation. 2009;120(5):e29–e30. doi:10.1161/CIRCULATIONAHA.109.849281
   Web of Science ®Google Scholar
• Kumar P, Kusumoto FM, Goldschlager N. Bradyarrhythmias in the elderly. Clin Geriatr Med. 2012;28(4):703–715. doi:10.1016/j.cger.2012.08.004
   PubMed Web of Science ®Google Scholar
• Buellesfeld L, Stortecky S, Heg D, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60(6):493–501. doi:10.1016/j.jacc.2012.03.054
   PubMed Web of Science ®Google Scholar
• Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129(11):1233–1243. doi:10.1161/CIRCULATIONAHA.113.005479
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA News Release. 2011. Web site. http://www.fda.gov/NewsEvents/Newsroom/Press-Announcements/ucm278348.htm
   Google Scholar
• Reinohl J, Kaier K, Reinecke H, et al. Effect of availability of transcatheter aortic-valve replacement on clinical practice. N Engl J Med. 2015;373(25):2438–2447. doi:10.1056/NEJMoa1500893
   Web of Science ®Google Scholar
• Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual Report of the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. J Am Coll Cardiol. 2017;69(10):1215–1230. doi:10.1016/j.jacc.2016.11.033
   PubMed Web of Science ®Google Scholar
• Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107(23):2932–2937. doi:10.1161/01.CIR.0000072769.17295.B1
   PubMed Web of Science ®Google Scholar
• Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350(9086):1210–1216. doi:10.1016/S0140-6736(97)03425-9
   PubMed Web of Science ®Google Scholar
• Chorianopoulos E, Krumsdorf U, Pleger ST, Katus HA, Bekeredjian R. Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve((R)) aortic bioprosthesis. Clin Res Cardiol. 2012;101(5):349–355. doi:10.1007/s00392-011-0398-9
   Web of Science ®Google Scholar
• Biancari F, Rosato S, D’Errigo P, et al. Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol. 2016;117(2):245–251. doi:10.1016/j.amjcard.2015.10.036
   Web of Science ®Google Scholar
• Beohar N, Whisenant B, Kirtane AJ, et al. The relative performance characteristics of the logistic European system for cardiac operative risk evaluation score and the Society of Thoracic Surgeons score in the placement of aortic transcatheter valves trial. J Thorac Cardiovasc Surg. 2014;148(6):2830–7 e1. doi:10.1016/j.jtcvs.2014.04.006
   Web of Science ®Google Scholar
• Edwards FH, Cohen DJ, O’Brien SM, et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol. 2016;1(1):46–52. doi:10.1001/jamacardio.2015.0326
   PubMed Web of Science ®Google Scholar
• Iung B, Laouenan C, Himbert D, et al. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart. 2014;100(13):1016–1023. doi:10.1136/heartjnl-2013-305314
   PubMed Web of Science ®Google Scholar